NEWS

Updates on OXGENE's Discovery and Biomanufacturing technologies

16 November 2017

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience...

View Details

Oxford Genetics Supports Significant Growth with New U.S. Office

12 Sep 2017

Oxford Genetics Secures £7.5 Million Investment

21 Aug 2017

Oxford Genetics Signs Worldwide Distribution Agreement With CLS Cell Lines Service

06 Mar 2017

Oxford Genetics receives Innovate UK grant to further develop mammalian display technologies for antibody discovery

14 Feb 2017

Oxford Genetics secures £1.61m Innovate UK grant to establish next-generation bioproduction technologies

05 Jan 2017

Oxford Genetics is awarded grant to create virus packaging cell lines

06 Dec 2016

£1m investment into Oxford Genetics following expansion of Board and opening of new facilities

01 Nov 2016

Oxford Genetics Strengthens Board with the Appointment of Three Industry Veterans

05 Sep 2016

Oxford Genetics extends its synthetic biology capabilities with ERS Genomics’ CRISPR Gene Editing Technology

09 May 2016

Oxford Genetics Partners with Sigma-Aldrich on Plasmid Distribution

08 Sep 2014